Forum Financial Management’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-1,414
Closed -$389K – 996
2025
Q4
$389K Buy
1,414
+10
+0.7% +$2.73K 0.01% 614
2025
Q3
$368K Buy
1,404
+203
+17% +$49.3K 0.01% 621
2025
Q2
$263K Hold
1,201
– – ﹤0.01% 742
2025
Q1
$269K Buy
+1,201
New +$331K ﹤0.01% 650
2024
Q2
– Sell
-605
Closed -$239K – 777
2024
Q1
$239K Hold
605
– – ﹤0.01% 615
2023
Q4
$213K Hold
605
– – ﹤0.01% 620
2023
Q3
$227K Hold
605
– – 0.01% 538
2023
Q2
$231K Buy
605
+5
+0.8% +$1.79K 0.01% 549
2023
Q1
$208K Buy
+600
New +$175K 0.01% 553
2022
Q2
– Sell
-600
Closed -$246K – 664
2022
Q1
$246K Hold
600
– – 0.01% 480
2021
Q4
$281K Buy
+600
New +$258K 0.01% 447

Other funds holding WST

Forum Financial Management's WST Position: Q1 2026 in Review

Forum Financial Management sold out of West Pharmaceutical (WST) in Q1 2026, closing a stake of 1,414 shares — an estimated $389K sold.

Forum Financial Management first reported a position in WST in Q4 2021 and held it in 11 quarters. The position peaked at $389K in Q4 2025. 755 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Forum Financial Management reported no remaining West Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • Forum Financial Management sold 1,414 West Pharmaceutical shares in Q1 2026, an estimated $389K.
  • Forum Financial Management first reported a position in West Pharmaceutical in Q4 2021 and held it in 11 quarters.
  • Forum Financial Management's West Pharmaceutical position peaked at $389K in Q4 2025.
  • 755 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Forum Financial Management's 13F filing for Q1 2026, filed 23 Apr 2026.